PTN
PTN
AMEX · Biotechnology

Palatin Technologies Inc

$6.57
-0.29 (-4.23%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +102.0% upside
Low Target $11.80
Average Target $13.27
High Target $20.48
Current Price $6.57
Current
$6.57
Target
$13.27
$11.80 $13.27 avg $20.48
Scenario Analysis
Bear Case
$11.80
79.6%
Low target
Base Case
$13.27
+102.0%
Avg target
Bull Case
$20.48
+211.7%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$31.00
-78.8% from high
52-Week Low
$4.51
+45.7% from low
Target vs 52W High
$13.27
-57.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%